Adipose–Brain Aging Axis
Current understanding
Dysfunctional visceral adipose tissue is proposed as a systemic modulator of brain aging via chronic low-grade inflammation, impaired insulin signaling, adipokine imbalance (leptin/adiponectin), SASP output from senescent adipocytes, and adipose-derived extracellular vesicles, while subcutaneous and thermogenic (brown/beige) depots may be neutral or protective [expert-opinion]. Framework is a synthesis of epidemiological, neuroimaging, and preclinical mechanistic data [expert-opinion] with no direct human interventional test that depot-specific remodeling alters brain-aging trajectories. Overlaps heavily with inflammaging, cellular senescence, vascular aging, and neurovascular-interface aging pages.
Evidence log
- 2026-09-23 — Lsp2 links mTORC1 to TOP mRNA translation and lifespan in Drosophila.: cross-connection with mtor-nutrient-sensing: Lsp2 acts from adipose tissue as a nutrient-induced amplifier of mTORC1 translational output that constrains organismal lifespan, positioning fat body as an endocrine origin of systemic nutrient-sensing tone. (novelty: 4)
- 2026-06-01 — Adipose tissue as a systemic modulator of brain aging: mechanistic links between metabolism, inflammation and neurodegeneration.: cross-connection with neurovascular-interface-aging: Adipose-derived inflammatory and metabolic signals are proposed as an upstream peripheral input to the aged heart–brain neurovascular interface, extending the NVI framework beyond cardiac-origin drivers. (novelty: 3)